To investigate which biological consequences might result from the reverse signaling of the CXCL16-CXCR6 axis, we first referred to the effects observed with inverse signaling in glioma cells [13] and tested the proliferative and anti-apoptotic effects in LOX-CXCL16 and corresponding control clones. This evidence concerns the gene CXCR6 and central nervous system cancer.